Explanation for the choice of comparators {6b}
malaria
MALARIA
Participants in the control group will receive albendazole. The main rationale for this is ethical. While there is clear equipoise (that is, lack of evidence whether ivermectin works as intended) for the potential benefit of ivermectin regarding malaria transmission, ivermectin has proven efficacy against Albendazole serves three purposes in the design of these trials:It provides participants in the control group with the benefit of dewormingIt helps with acceptability as participants in both groups will pass wormsIt increases comparability given some deworming in both groups